Haemonetics Corporation (HAE) Debt/EBITDA US GAAP (year values) |
|||||||||
2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 3.03 | 1.93 | 1.93 | 2.28 | 2.64 | ||||
Changes by years, y/y, % | -16% | -36% | 0% | -100% | +19.4% |
Haemonetics Corporation. Debt/EBITDA
Haemonetics Corporation. Debt/EBITDA, changes, %
Haemonetics Corporation (HAE) Debt/EBITDA US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
Debt/EBITDA | 1.44 | 1.66 | 2.62 | 2.41 | 2.50 | 2.64 | ||
Changes by years, y/y, % | -43% | -25% | +26% | +28% | +33% | |||
Changes by quarters, q/q, % | -23% | +15% | +58% | -8% | +4% |